钝性胸主动脉损伤腔内修复的长期结局:10年多中心经验
这项回顾性观察研究在3个中心纳入2010年1月至2019年12月连续62例接受胸主动脉腔内修复(TEVAR)的钝性胸主动脉损伤(BTAI)患者,技术成功率100%,院内死亡率1.61%(n=1),平均随访86.82±30.58个月,全因随访死亡率3.28%(n=2),结论认为TEVAR对BTAI具有长期安全性和有效性。
要点
- 62例BTAI患者TEVAR技术成功率100%,院内死亡1例(1.61%)。
- 平均随访86.82±30.58个月,全因随访死亡2例(3.28%),无脊髓缺血、内漏或支架移位。
- 随访发现3例(4.92%)弓上分支狭窄或闭塞,其中2例(3.28%)需再干预。
核心结论
- 本研究证实TEVAR治疗BTAI具有长期安全性和有效性。
- 对于年轻BTAI患者,随着胸主动脉随年龄增长,需要更长随访以观察支架与主动脉之间可能的不匹配。
研究设计与样本
- 回顾性观察研究,2010年1月至2019年12月在3个中心连续纳入62例接受TEVAR的BTAI患者。
- 计划术后6个月行计算机断层血管造影(CTA)检查,此后每年复查。
主要发现
- 全部62例手术技术成功(100%),包括夹层35例(56.45%)、假性动脉瘤20例(32.26%)、破裂7例(11.29%)。
- 平均损伤严重度评分为31.66±8.30。
- 通过烟囱技术重建弓上分支21支,其中左锁骨下动脉(LSA)12例、左颈总动脉9例;另有11例LSA在术中覆盖。
- 院内死亡率为1.61%(n=1),平均随访86.82±30.58个月,全因随访死亡率为3.28%(n=2)。
- 随访发现3例(4.92%)弓上分支狭窄或闭塞,其中2例(3.28%)需再干预;未观察到脊髓缺血、内漏或支架移位。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to assess the long-term outcomes in patients treated by thoracic endovascular aortic repair (TEVAR) for blunt thoracic aortic injuries (BTAI). MATERIALS AND METHODS: From January 2010 to December 2019, this retrospective observational study was conducted at 3 centers, involving 62 consecutive BTAI patients who underwent TEVAR. Computed tomography angiography scans were planned to be conducted at 6 months post-procedure, and annually thereafter. RESULTS: Technical success was achieved in all 62 procedures (100%), which included cases of dissection (n=35, 56.45%), pseudoaneurysm (n=20, 32.26%), and rupture (n=7, 11.29%). Mean injury severity score was 31.66±8.30. A total of 21 supra-arch branches were revascularized by chimney technique, with 12 cases involving the left subclavian artery (LSA) and 9 cases involving the left common carotid artery. In addition, 11 LSAs were covered during the procedure. The in-hospital mortality rate was 1.61% (n=1). The mean follow-up time was 86.82±30.58 months. The all-cause follow-up mortality rate was 3.28% (n=2). Stenosis or occlusion of 3 supra-arch branches (4.92%) was identified at follow-up, with 2 cases (3.28%) requiring re-intervention. No spinal cord ischemia, endoleak, or migration was observed. CONCLUSIONS: Despite only including patients with long-term follow-up, this study confirms the long-term safety and effectiveness of TEVAR for BTAI. For young BTAI patients, as the thoracic aorta increases with age, longer follow-up is needed to observe the potential mismatch between the endograft and the aorta.Clinical ImpactThis study confirms the long-term safety and effectiveness of endovascular treatment for blunt thoracic aortic injury (BTAI). For young BTAI patients, as the thoracic aorta increases with age, longer follow-up is needed to observe the potential mismatch between the endograft and the aorta. Through a remarkably extended follow-up period (86.82±30.58 months) conducted at multiple centers in China, this study confirms the long-term safety and effectiveness of endovascular treatment for BTAI.
引用
- Wu M, Zeng Z, Bao X, et al. Long-term Outcomes of Endovascular Repair for Blunt Thoracic Aortic Injury: A 10 Year Multi-center Experience. J Endovasc Ther. 2024. PMID: 38605568. doi:10.1177/15266028241245326
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。